Ward R A
Department of Medicine, School of Medicine, University of Louisville, Ky 40292, USA.
Blood Purif. 1995;13(3-4):153-9. doi: 10.1159/000170198.
Limitations of dialyzer reuse technology may contribute to adverse patient outcomes. Assessing changes in dialyzer performance by measuring changes in total cell volume may not be valid for all membranes and reprocessing methods. Systems which determine dialyzer performance on-line are superior. Compliance with standards for microbial contamination of reprocessing fluids is poor and improvements in water treatment system design and monitoring are needed. Technological innovation is required to enable dialyzer performance to be monitored over an expanded molecular weight range and to ensure that dialyzer reprocessing can be routinely performed with sterile, non-pyrogenic solutions.
透析器复用技术的局限性可能导致不良的患者预后。通过测量总细胞容积的变化来评估透析器性能的变化,对所有膜和再处理方法而言可能并不有效。在线测定透析器性能的系统更具优势。再处理液的微生物污染标准的合规性较差,需要改进水处理系统的设计和监测。需要进行技术创新,以便能够在更宽的分子量范围内监测透析器性能,并确保透析器再处理能够常规地使用无菌、无热原的溶液进行。